Cardiff Oncology (CRDF) Assets Average (2012 - 2026)

Cardiff Oncology has reported Assets Average for 14 years, with the latest figure at $62.8 million in Q4 2025.

• Quarterly Assets Average fell 21.5% year-over-year to $62.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62.8 million (down 21.5% YoY) and the FY2025 annual result came in at $79.5 million, down 11.05% from the prior year.
• Assets Average declined to $62.8 million in Q4 2025 per CRDF's latest filing, from $69.8 million in the prior quarter.
• Over five years, Assets Average peaked at $145.4 million in Q4 2021 and troughed at $62.8 million in Q4 2025.
• A 5-year average of $103.6 million and a median of $97.5 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2021 and 2024: Assets Average jumped 961.36% in 2021, then tumbled 31.33% in 2024.
• Over 5 years, Assets Average stood at $145.4 million in 2021, then fell by 17.55% to $119.9 million in 2022, then retreated by 29.08% to $85.0 million in 2023, then slipped by 5.88% to $80.0 million in 2024, then decreased by 21.5% to $62.8 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $62.8 million, $69.8 million, and $80.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.